O. Suzuki

S. Ohira, Y. Ueda, M. Miyazaki, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

A robust measurement point for dose verification in delivery quality assurance for a robotic radiosurgery system

H. Shiomi, K. Tamari, K. Ogawa, 2016, Journal of radiation research.

Poly (ADP-ribose) polymerase inhibitors sensitize cancer cells to hypofractionated radiotherapy through altered selection of DNA double-strand break repair pathways

Y. Akino, K. Tamari, K. Ogawa, 2021, International journal of radiation biology.

Quantitative evaluation of changes in irradiated lung fields after stereotactic irradiation by the Polygon Method.

Hironobu Nakamura, E. Tanaka, H. Shiomi, 2004, Radiation medicine.

Significance of endoscopic screening and endoscopic resection for esophageal cancer in patients with hypopharyngeal cancer.

R. Ishihara, A. Imai, Y. Tomita, 2010, Japanese journal of clinical oncology.

Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2016, Brachytherapy.

Long-term Outcomes of Radiotherapy Regimen of 72 Gy in 30 Fractions for Prostate Cancer

H. Shiomi, K. Tamari, K. Ogawa, 2018, AntiCancer Research.

Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening.

K. Tamari, Zhihao Li, K. Ogawa, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of rotational setup error on tumor shift in bony anatomy matching measured with pulmonary point registration in stereotactic body radiotherapy for early lung cancer.

Yoshihiro Ueda, K. Tsujii, Masayoshi Miyazaki, 2012, Japanese journal of clinical oncology.

Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.

Y. Yoshioka, H. Shiomi, M. Koizumi, 2013, Japanese journal of clinical oncology.

Validation of the liver mean dose in terms of the biological effective dose for the prevention of radiation-induced liver damage.

Daisaku Tatsumi, Hiroya Shiomi, Norihisa Masai, 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors

K. Hayashi, Y. Yoshioka, S. Mabuchi, 2014, Journal of radiation research.

Clinical Significance of the Apparent Diffusion Coefficient Ratio in Prostate Cancer Treatment with Intensity-modulated Radiotherapy.

M. Hori, N. Tomiyama, Y. Yoshioka, 2016, Anticancer research.

Impact of accumulated alterations in driver and passenger genes on response to radiation therapy.

K. Tamari, K. Ogawa, I. Sumida, 2020, The British journal of radiology.

Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG).

M. Hiraoka, T. Teshima, T. Nakano, 2010, International journal of radiation oncology, biology, physics.

The Promising Treatment Schedule of Concurrent Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Alternative for Conventional Fractionation Using Mathematical Analysis

S. Ohira, Y. Ueda, M. Miyazaki, 2020, AntiCancer Research.

Local and disease control for nasal melanoma treated with radiation and concomitant anti‐programmed death 1 antibody

M. Fujimoto, K. Ogawa, A. Tanemura, 2020, The Journal of dermatology.

Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer.

H. Shiomi, R. Oh, N. Masai, 2017, Oncology letters.

Treatment outcomes using CyberKnife for brain metastases from lung cancer

T. Yoshimine, Y. Yoshioka, K. Tamari, 2014, Journal of radiation research.

11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.

E. Shimosegawa, J. Hatazawa, H. Kishima, 2019, Journal of neurosurgery.

Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.

Y. Yoshioka, Yoshifumi Yamamoto, T. Yoshii, 2015, International journal of radiation oncology, biology, physics.

Feasibility of synthetic computed tomography generated with an adversarial network for multi-sequence magnetic resonance-based brain radiotherapy

Osamu Suzuki, Iori Sumida, Kazuhiko Ogawa, 2019, Journal of radiation research.

Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach.

K. Hayashi, Y. Yoshioka, K. Tamari, 2016, The British journal of radiology.

BJRD15724 1..13

K. Hayashi, Y. Yoshioka, K. Tamari, 2016 .

Assessment of Daily Replanning and Geometrical Variation of High-dose-rate Brachytherapy for the Prostate

Y. Yoshioka, Y. Akino, T. Hirata, 2020, AntiCancer Research.

Defining PET standardized uptake value threshold for tumor delineation with metastatic lymph nodes in head and neck cancer.

Satoaki Nakamura, K. Nishiyama, M. Morimoto, 2012, Japanese journal of clinical oncology.

High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up.

Y. Yoshioka, H. Yamazaki, K. Ogawa, 2016, International journal of radiation oncology, biology, physics.

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

Kazuhiko Ogawa, Yasuo Yoshioka, Ken Yoshida, 2014, Journal of contemporary brachytherapy.

Monotherapeutic high-dose-rate brachytherapy for prostate cancer: a dose reduction trial.

Y. Yoshioka, H. Yamazaki, M. Koizumi, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intracavitary brachytherapy for carcinoma of the uterine cervix—Comparison of HDR (Ir-192) and MDR (Cs-137)—

E. Tanaka, T. Teshima, R. Oh, 2006, Radiation Medicine.

Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.

Y. Yoshioka, H. Shiomi, Satoaki Nakamura, 2008, International journal of radiation oncology, biology, physics.

Reirradiation for locally recurrent lung cancer in the chest wall with boron neutron capture therapy (BNCT)

K. Ono, Minoru Suzuki, Y. Sakurai, 2012, International Cancer Conference Journal.

Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results

Y. Yoshioka, Y. Akino, M. Koizumi, 2014, International Journal of Clinical Oncology.

Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam.

Y. Yoshioka, M. Hasegawa, K. Ogawa, 2015, Medical physics.

Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis

H. Yamazaki, N. Katoh, H. Ogino, 2022, Cancers.

Long-term results of intraoperative extracorporeal irradiation of autogenous bone grafts on primary bone and soft tissue malignancies

K. Hayashi, H. Yoshikawa, Y. Yoshioka, 2015, Acta oncologica.

The Outcomes of Induction Chemoradiotherapy Followed by Surgery for Clinical T3-4 Non-Small Cell Lung Cancer

M. Okumura, K. Ogawa, A. Kumanogoh, 2019, Technology in cancer research & treatment.

Y. Yoshioka, S. Mabuchi, K. Tamari, 2015, Radiation oncology.

Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis

H. Shiomi, T. Hirata, K. Tamari, 2021, AntiCancer Research.

High-dose-rate brachytherapy combined with long-term hormonal therapy for high-risk prostate cancer: Results of a retrospective analysis

Masahiro Kato, Y. Yoshioka, E. Tanaka, 2006, Radiation Medicine.

Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients

H. Onishi, K. Katsui, K. Nagata, 2020, AntiCancer Research.

Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group

Y. Yoshioka, A. Imai, K. Ogawa, 2012, Journal of radiation research.

818 poster AN INVESTIGATION OF SEQUENTIAL BOOST IMRT VERSUS SIB IMRT FOR HEAD AND NECK CANCER

H. Takegawa, Satoaki Nakamura, O. Suzuki, 2011 .

External-Beam Radiotherapy for Clinically Localized Prostate Cancer in Osaka, Japan, 1995–2006

Y. Yoshioka, H. Yamazaki, E. Tanaka, 2009, Strahlentherapie und Onkologie.

Characteristics of microSilicon diode detector for electron beam dosimetry.

Y. Akino, I. Das, K. Tamari, 2021, Journal of radiation research.

Characterization of a microSilicon diode detector for small-field photon beam dosimetry

H. Shiomi, Y. Akino, K. Tamari, 2020, Journal of radiation research.

Comparison of gamma index based on dosimetric error and clinically relevant dose–volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy

K. Tamari, K. Ogawa, I. Sumida, 2019, Radiation oncology.

Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution.

Y. Yoshioka, K. Ogawa, I. Sumida, 2015, International journal of radiation oncology, biology, physics.

Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).

M. Hiraoka, T. Teshima, T. Nakano, 2012, International journal of radiation oncology, biology, physics.

A new plan quality objective function for determining optimal collimator combinations in prostate cancer treatment with stereotactic body radiation therapy using CyberKnife

Y. Yoshioka, H. Shiomi, K. Ogawa, 2018, PloS one.

Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net

H. Yamazaki, H. Sakurai, N. Katoh, 2023, Clinical and translational radiation oncology.

Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate

Y. Shiki, Y. Yoshioka, E. Tanaka, 2015, Journal of radiation research.

Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study

Y. Yoshioka, T. Hirata, K. Tamari, 2023, Acta oncologica.

The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors

T. Kanou, M. Okumura, K. Tamari, 2020, Journal of Cardiothoracic Surgery.

Salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy for prostate cancer: a single-center experience.

Takahiro Yoshida, M. Nakayama, K. Nishiyama, 2011, Japanese journal of clinical oncology.

Dosimetric impact of intra-fraction prostate motion under a tumour-tracking system in hypofractionated robotic radiosurgery

Y. Yoshioka, H. Shiomi, K. Tamari, 2018, PloS one.

RTHP-37. IMPACT OF 11C-METHIONINE/FDG DURAL TRACER PET-BASED, COMPARED WITH MRI-BASED TARGET DELINEATION OF MALIGNANT GLIOMAS FOR RADIATION PLANNING

E. Shimosegawa, J. Hatazawa, H. Kishima, 2018, Neuro-Oncology.

Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma.

Y. Yoshioka, M. Koizumi, I. Sumida, 2010, International journal of radiation oncology, biology, physics.

Particle beam therapy versus photon radiotherapy for extrahepatic biliary cancer—systemic review and meta-analysis

H. Yamazaki, S. Teramukai, M. Ohtsuka, 2023, Journal of radiation research.

Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer

M. Monden, T. Ueda, I. Takemasa, 2006, World journal of surgical oncology.

Risk factors for pericardial effusion in patients with stage I esophageal cancer treated with chemoradiotherapy.

Y. Doki, M. Mori, Y. Yoshioka, 2014, Anticancer research.

Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: a Japanese national registry study (J-CROS-LUNG).

Y. Shioyama, M. Satouchi, H. Ishikawa, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dosimetric and clinical effects of interfraction and intrafraction correlation errors during marker-based real-time tumor tracking for liver SBRT

H. Shiomi, K. Tamari, K. Ogawa, 2017, Journal of radiation research.

Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife

H. Kishima, K. Hayashi, H. Shiomi, 2019, AntiCancer Research.

Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors

H. Shiomi, T. Hirata, K. Tamari, 2023, BMC Cancer.